Clinical Characteristics and Outcomes of Lung Cancer Patients 
with EGFR Mutations in Exons 19 and 21

Clinical Characteristics and Outcomes of Lung Cancer Patients 
with EGFR Mutations in Exons 19 and 21

Background and objective Studies on the epidermal growth factor receptor (EGFR) signaling pathways and the therapeutic effects of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) have recently proven that targeted therapy has a major role in the treatment of lung cancer. However, the therapeutic effects...

Full description

Bibliographic Details
Main Authors: Renwang LIU, Jinghao LIU, Xin LI, Ying LI, Qingchun ZHAO, Zuosheng LI, Hongyu LIU, Jun CHEN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EGFR
Target therapy
Prognosis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.06

Similar Items